Invista 100 mg Tablet

Invista 100 mg Tablet contains dasatinib 100 mg, a targeted anticancer medicine used for certain blood cancers. It is an oral prescription tablet used as directed by an oncologist. Dasatinib works by blocking abnormal tyrosine kinase activity involved in cancer-cell growth.

BUY NOW

Invista 100 mg Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib belongs to the BCR-ABL tyrosine kinase inhibitor class and helps inhibit abnormal signaling that supports leukemia-cell proliferation. The dose and treatment duration are determined by the treating specialist according to the disease type, treatment response, and individual patient factors. Invista 100 mg is marketed by Dr. Reddy’s Laboratories Ltd. and is commonly supplied in a 10-tablet strip in India.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 100 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer/Marketer Dr. Reddy’s Laboratories Ltd.

Product Also Known As

Invista 100 mg Tablet, Invista 100 Tablet, Invista Dasatinib 100 mg, Dasatinib 100 mg Tablet, Dasatinib Leukemia Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet